✦ LIBER ✦

Combined Interferon and Lamivudine Therapy: Is This The Treatment of Choice for Patients With Chronic Hepatitis B Virus Infection?

✍ Scribed by Norah A. Terrault

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 95 KB
Volume: 32
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510320338

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term beneficial effect of interfero

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

✍ Shi-Ming Lin; I-Shyan Sheen; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5

Predictive model of response to therapy

Predictive model of response to therapy with interferon in patients with chronic hepatitis B virus infection: A methodological note

✍ Gioacchino Leandro; M. G. Brook; P. Karayiannis; H. C. Thomas 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

Prevalence and profile of mutations asso

Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus

✍ Salma M. Wakil; Syed N. Kazim; Luqman A. Khan; Sheikh Raisuddin; Mohammad K. Par 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract Lamivudine results in the selection of resistant hepatitis B virus (HBV) variants. Because the surface gene of HBV overlaps completely the polymerase gene, the incidence and profile of surface and polymerase gene mutations were investigated prospectively in chronic HBV patients who were

Pilot study of combination therapy with

Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody–positive patients

✍ Teresa Cotonat; Juan Antonio Quiroga; Juan Manuel López-Alcorocho; Rosa Clouet; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Cost effectiveness of interferon α2b com

Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C

✍ Zobair M. Younossi; Mendel E. Singer; John G. McHutchison; Kenneth M. Shermock 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Treatment of chronic hepatitis C with Interferon (IFN) ␣2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated